Both in Biotechnology
Editas Medicine vs Allogene Therapeutics
Over the past year EDIT returned −12.7% and ALLO returned 0.0%; their daily moves had a correlation of 0.47.
EDIT −12.7% ALLO 0.0%Growth of $1, one year, split-adjusted
| Metric | EDIT | ALLO |
|---|---|---|
| Price | $2.67 | $1.18 |
| Market cap | $410.1M | $407.7M |
| Today | −8.87% | −5.60% |
| 1 month | +6.0% | −23.4% |
| 6 months | −7.9% | −45.1% |
| Year to date | +30.2% | −13.9% |
| 1 year | −12.2% | −3.3% |
| Revenue growth (YoY) | +232.3% | — |
| Gross margin | 100.0% | 100.0% |
| Net margin | −153.3% | −919.8% |
| P/E (TTM) | — | — |
| Price / sales | 8.7× | 87.9× |
| Net cash | $155.9M | $332.6M |
| Dividend yield | — | — |
| Volatility (60d) | 81.4% | 53.4% |
| Short % of float | 25.7% | 19.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).